Prostate cancer-associated polyarteritis nodosa: improvement of clinical manifestations after prostatectomy.

Authors:
Toshiyuki Watanabe
Toshiyuki Watanabe
Shiga University of Medical Science
Japan
Masatoshi Kanda
Masatoshi Kanda
Hokkaido University Hospital.
Keisuke Kikuchi
Keisuke Kikuchi
Obihiro Kosei General Hospital
Japan

Clin Exp Rheumatol 2018 Mar-Apr;36 Suppl 111(2):167-168. Epub 2018 Jan 11.

Department of Pathology, Obihiro-Kosei General Hospital, Obihiro, Japan.

January 2018
7 Reads

Similar Publications

[The changing face of medium-sized vasculitis].

Wiad Lek 2018 ;71(1 pt 1):64-72

Studia Doktoranckie, Zakład Farmakologii, Wydział Nauk o Zdrowiu, Uniwersytet Medyczny, Lublin.

Polyarteritis nodosa is a systemic necrotizing vasculitis which predominantly affects medium-sized arteries. It is a rare disease nowadays. Both the nomenclature and the classification of polyarteritis nodosa was amended several times in the past. Read More

View Article
January 2018

Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy.

Ophthalmology 1993 Dec;100(12):1775-81

Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston 02114.

Background: Polyarteritis nodosa is a necrotizing vasculitis affecting medium and small-sized arteries throughout the body, including ocular tissues. Untreated polyarteritis nodosa carries a very poor prognosis. Treatment with steroids increases the 5-year survival to 48%, whereas addition of cytotoxic immunosuppressive treatment improves the outcome dramatically. Read More

View Article
December 1993

Diplopia and myalgia: potential heralding symptoms of polyarteritis nodosa.

Am J Clin Dermatol 2007 ;8(3):175-8

Department of Dermatology and Allergology, Friedrich-Schiller-University of Jena, Jena, Germany.

Protean clinical manifestations of polyarteritis nodosa are described. Hence, a sequential multidisciplinary diagnostic approach, including thorough dermatologic examination and histologic verification in particular, are warranted in patients suspected of having this condition. The lack of both pathognomonic visceral and/or cutaneous features and specific serologic tests for identifying polyarteritis nodosa explains why making the diagnosis is often delayed. Read More

View Article
August 2007

Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up.

Hepatology 1989 Jan;9(1):97-101

Alaska Native Medical Center, Indian Health Service, Anchorage 99510.

We analyzed the demographic, clinical, laboratory and histologic features of 13 patients who were diagnosed as having polyarteritis nodosa associated with hepatitis B virus infection over a 12-year period, 1974 to 1985. All 13 patients were Yupik Eskimos and resided in southwest Alaska, an area hyperendemic for hepatitis B virus infection. The annual incidence of hepatitis B virus-associated polyarteritis nodosa for this population is 7. Read More

View Article
January 1989